Canine leishmaniosis in South America

Department of Veterinary Public Health, Faculty of Veterinary Medicine, University of Bari, 70010 Valenzano, Bari, Italy. .
Parasites & Vectors (Impact Factor: 3.25). 02/2009; 2 Suppl 1(Suppl 1):S1. DOI: 10.1186/1756-3305-2-S1-S1
Source: PubMed

ABSTRACT ABSTRACT : Canine leishmaniosis is widespread in South America, where a number of Leishmania species have been isolated or molecularly characterised from dogs. Most cases of canine leishmaniosis are caused by Leishmania infantum (syn. Leishmania chagasi) and Leishmania braziliensis. The only well-established vector of Leishmania parasites to dogs in South America is Lutzomyia longipalpis, the main vector of L. infantum, but many other phlebotomine sandfly species might be involved. For quite some time, canine leishmaniosis has been regarded as a rural disease, but nowadays it is well-established in large urbanised areas. Serological investigations reveal that the prevalence of anti-Leishmania antibodies in dogs might reach more than 50%, being as high as 75% in highly endemic foci. Many aspects related to the epidemiology of canine leishmaniosis (e.g., factors increasing the risk disease development) in some South American countries other than Brazil are poorly understood and should be further studied. A better understanding of the epidemiology of canine leishmaniosis in South America would be helpful to design sustainable control and prevention strategies against Leishmania infection in both dogs and humans.


Available from: Filipe Dantas-Torres, Jun 14, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: It has been nearly 10 years since the completion of the first entire genome sequence of a Leishmania parasite. Genomic and transcriptomic analyses have advanced our understanding of the biology of Leishmania, and shed new light on the complex interactions occurring within the parasite–host–vector triangle. Here, we review these advances and examine potential avenues for translation of these discoveries into treatment and control programs. In addition, we argue for a strong need to explore how disease in dogs relates to that in humans, and how an improved understanding in line with the ‘One Health’ concept may open new avenues for the control of these devastating diseases.
    Trends in Parasitology 01/2015; 7(3). DOI:10.1016/ · 6.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Com o objetivo de avaliar os fatores de risco e a classificação clínica associados à soropositividade para Leishmaniose Visceral Canina (LVC) no município de Colares, estado do Pará, foram coletadas e analisadas 435 amostras de soro sanguíneo de cães de ambos os sexos, idade a partir de 4 meses, com ou sem de raça definida e com ou sem sintomatologia clínica sugestiva da doença, dos bairros e das localidades da zona rural. A sorologia foi realizada empregando-se os métodos Ensaio Imunoenzimático (ELISA/S7) e Reação de Imunofluorescência Indireta (RIFI), em lâminas fixadas com antígenos de Leishmania infantum. O sexo não apresentou significância estatística (P > 0,05). Observou-se prevalência significativa de LVC com relação à faixa etária e classificação clínica (P < 0,05). A prevalência foi maior para cães na faixa etária menor de 2 anos e para os classificados clinicamente como sintomáticos, sendo que onicogrifose e alterações cutâneas foram as alterações clínicas mais frequentes.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: American cutaneous leishmaniasis (ACL) caused by Leishmania (Viannia) braziliensis is a neglected disease of humans in the New World that may also cause irreversible skin and eventually mucocutaneous lesions. This parasite can also infect dogs and represents a diagnostic challenge for veterinarians. Methods currently available for the diagnosis of ACL have a low sensitivity and may be time-consuming, representing a limit for treatment expedition of ACL. Quantitative real time PCR assays (qPCR) for the detection of L. (V.) braziliensis in canine blood samples were developed herein, and the detection limit and specificity of different molecular targets (kDNA and rDNA) evaluated. Of the protocols assessed, two qPCR assays, one targeting the kDNA and other the SSU rDNA of L. (V.) braziliensis, performed better, with detection limits of 100 fg and 10 pg, respectively. These assays were also used to test skin samples from humans with suspected ACL. The results indicate that the qPCR protocols developed represent an advance for the diagnosis of ACL in dogs and humans from this region, and provide a rapid and non-invasive diagnosis of the infection by L. (V.) braziliensis. Considering the quantitative nature of the assays, they will also be useful for monitoring treatment efficacy and preventing relapses in human patients in Brazil, although further studies are needed to critically evaluate the specificity of the qPCRs for their capacity to distinguish different Leishmania species and subspecies (represented by zymodemes) in other countries. Finally, molecular assays established may represent new tools for future basic and applied research focused on species identification, host-parasite associations, and infection dynamics in host and vector populations.
    Molecular and Cellular Probes 02/2013; DOI:10.1016/j.mcp.2013.01.003 · 1.86 Impact Factor